Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

BACKGROUND: Human epidermal growth factor receptor 2(HER2) status is a crucial predictive factor for prognostic assessment and targeted therapy selection, which may be influenced by intratumor heterogeneity and molecular divergence between the primary site and different metastases. Therefore, we per...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiuwen, Liu, Binliang, Niu, Yunyun, Dong, Xin, Zhu, Xia, Li, Chunxiao, Li, Lixi, Yi, Zongbi, Sun, Xiaoying, Chen, Hongyan, Lu, Sijia, Ma, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375665/
https://www.ncbi.nlm.nih.gov/pubmed/31927339
http://dx.doi.org/10.1016/j.breast.2019.12.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375665/
https://www.ncbi.nlm.nih.gov/pubmed/31927339
http://dx.doi.org/10.1016/j.breast.2019.12.010

Ejemplares similares